Literature DB >> 15236290

Valproic acid treatment of glioblastoma multiforme in a child.

Olaf Witt, Lothar Schweigerer, Pablo Hernáiz Driever, Johannes Wolff, Arnulf Pekrun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15236290     DOI： 10.1002/pbc.20083

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  11 in total

1.  Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.

Authors:  Jack M Su; Xiao-Nan Li; Patrick Thompson; Ching-Nan Ou; Ashish M Ingle; Heidi Russell; Ching C Lau; Peter C Adamson; Susan M Blaney
Journal:  Clin Cancer Res       Date:  2010-11-29       Impact factor: 12.531

2.  Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.

Authors:  Chandra M Das; Peter E Zage; Pete Taylor; Dolly Aguilera; Johannes E A Wolff; Dean Lee; Vidya Gopalakrishnan
Journal:  Eur J Cancer       Date:  2010-10       Impact factor: 9.162

3.  DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.

Authors:  Mitsutoshi Kadowaki; Hiroki Yoshioka; Hideki Kamitani; Takashi Watanabe; Paul A Wade; Thomas E Eling
Journal:  Int J Cancer       Date:  2011-05-25       Impact factor: 7.396

4.  Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy.

Authors:  Eligija Damanskienė; Ingrida Balnytė; Angelija Valančiūtė; Marta Marija Alonso; Donatas Stakišaitis
Journal:  Biomedicines       Date:  2022-04-22

5.  Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Authors:  Preethi Prasad; Hernan Vasquez; Chandra M Das; Vidya Gopalakrishnan; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-10-14       Impact factor: 4.130

6.  Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma.

Authors:  Johannes E A Wolff; Christof Kramm; Rolf-Dieter Kortmann; Torsten Pietsch; Stefan Rutkowski; Norbert Jorch; Astrid Gnekow; Pablo Hernáiz Driever
Journal:  J Neurooncol       Date:  2008-08-05       Impact factor: 4.130

Review 7.  Targeting of histone deacetylases in brain tumors.

Authors:  Jonas Ecker; Olaf Witt; Till Milde
Journal:  CNS Oncol       Date:  2013-07

8.  Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.

Authors:  Chandra M Das; Dolly Aguilera; Hernan Vasquez; Preethi Prasad; Ming Zhang; Johannes E Wolff; Vidya Gopalakrishnan
Journal:  J Neurooncol       Date:  2007-05-30       Impact factor: 4.130

9.  Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.

Authors:  Jen-Ho Tseng; Cheng-Yi Chen; Pei-Chun Chen; Sheng-Huang Hsiao; Chi-Chen Fan; Yu-Chih Liang; Chie-Pein Chen
Journal:  Oncotarget       Date:  2017-02-28

10.  Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.

Authors:  R A Blaheta; M Michaelis; I Natsheh; C Hasenberg; E Weich; B Relja; D Jonas; H W Doerr; J Cinatl
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.